Spark Investment Management LLC Jounce Therapeutics, Inc. Transaction History

Spark Investment Management LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 12, 2019	SELL	$3.33 - $4.93 $40,626 - $60,146	-12,200 Closed	0 $0
Q2 2019 Aug 12, 2019	SELL	$4.3 - $6.73 $998,030 - $1.56 Million	-232,100 Reduced 95.01%	12,200 $60,000
Q1 2019 May 07, 2019	SELL	$3.43 - $6.87 $122,108 - $244,572	-35,600 Reduced 12.72%	244,300 $1.51 Million
Q4 2018 Feb 12, 2019	BUY	$2.69 - $6.71 $53,915 - $134,488	20,043 Added 7.71%	279,900 $943,000
Q3 2018 Nov 13, 2018	BUY	$6.5 - $8.37 $287,020 - $369,594	44,157 Added 20.47%	259,857 $1.69 Million
Q2 2018 Aug 08, 2018	BUY	$7.27 - $21.88 $1.13 Million - $3.4 Million	155,300 Added 257.12%	215,700 $1.65 Million
Q1 2018 May 10, 2018	SELL	$13.4 - $28.4 $1.21 Million - $2.56 Million	-90,100 Reduced 59.87%	60,400 $1.35 Million
Q4 2017 Feb 12, 2018	SELL	$12.52 - $17.82 $146,484 - $208,494	-11,700 Reduced 7.21%	150,500 $1.92 Million
Q3 2017 Nov 13, 2017	BUY	$11.17 - $16.99 $1.81 Million - $2.76 Million	162,200	162,200 $2.53 Million

720K

Ticker JNCE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 51,694,200
Description
Jounce Therapeutics, Inc., a clinical-stage immunotherapy company, develops therapies for the treatment of cancer. The company develops vopratelimab, a clinical-stage monoclonal antibody, which is in Phase II clinical trial that binds to and activates the Inducible T cell CO-Stimulator, a protein on the surface of T cells found in various solid ...

Get notified when there are updates to the investment portfolio of Spark Investment Management LLC, based on Form 13F filings with the SEC.

Stay updated on Spark Investment Management LLC with notifications on news.